ChemicalBook--->CAS DataBase List--->1414386-05-2

1414386-05-2

1414386-05-2 Structure

1414386-05-2 Structure
IdentificationBack Directory
[Name]

Sonelokimab
[CAS]

1414386-05-2
[Synonyms]

Sonelokimab
Research Grade Sonelokimab(DHH28808)
Chemical PropertiesBack Directory
[form ]

Liquid
[color ]

Colorless to light yellow
Hazard InformationBack Directory
[Uses]

Sonelokimab (ALX 0761) is a trivalent bispecific nanobody composed of camel derived humanized IL-17F antibodies, IL-17A/F antibodies, and serum albumin VHH antibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid arthritis and psoriasis[1][2][3][4].
[in vivo]

Sonelokimab (2.8 and 10 mg/kg, s.c., weekly intervals for 8 consecutive weeks) reduces IL-15, IL-6, MMP-3 and TNF-α expression and demonstrates the potential preventive effect of arthritis in a collagen-induced arthritis model in cynomolgus monkey[4].

Animal Model:A collagen-induced arthritis model in cynomolgus monkey[4]
Dosage:2.8 and 10 mg/kg
Administration:weekly intervals for 8 consecutive weeks
Result:Significantly improved X-ray score B and the arthritis score in a collagen-induced arthritis model in cynomolgus monkey.
[IC 50]

IL-17A; IL-17F
[References]

[1] Torres T, et al. A revolutionary therapeutic approach for psoriasis: bispecific biological agents. Expert Opin Investig Drugs. 2016 Jul;25(7):751-4. DOI:10.1080/13543784.2016.1187130
[2] Rossotti MA, et al. Immunogenicity and humanization of single-domain antibodies. FEBS J. 2022 Jul;289(14):4304-4327. DOI:10.1111/febs.15809
[3] Gao W, et al. Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis. Front Immunol. 2023 May 25;14:1151977. DOI:10.3389/fimmu.2023.1151977
[4] Vanheusden K, et al. Pre-clinical proof-of-concept of ALX-0761, a Nanobody? neutralizing both IL-17A and F in a cynomolgus monkey collagen induced arthritis model[C]//ARTHRITIS AND RHEUMATISM. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: Wiley-Blackwell, 2013, 65: S543-S543.
1414386-05-2 suppliers list
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Website: http://www.chemstan.com/
Company Name: Biolab Reagents  
Tel: 18108604356 18108604356
Website: www.biolabreagent.com/
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Website: https://www.jknbiochem.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: Atagenix Laboratories  
Tel: 027-87008169 17762441161
Website: www.abinscience.com/
Company Name: AntibodySystem Laboratories SAS  
Tel: 33175446423
Website: www.antibodysystem.com
Company Name: Biosynth Biological Technology (Suzhou) Co Ltd  
Tel: 51288865780
Website: www.biosynth.com
Company Name: Cell Sciences  
Tel: 9785721070
Website: www.cellsciences.com
Tags:1414386-05-2 Related Product Information
2072873-06-2 339986-90-2 677010-34-3 1024603-93-7 2231305-30-7 946415-13-0 380610-22-0 339186-68-4 569658-80-6 1044515-88-9

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.